• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆 pentraxin 3 与血清淀粉样蛋白 P 水平与强直性脊柱炎疾病活动度的关系。

The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis.

机构信息

Gaziler Physical Therapy and Rehabilitation Training and Research Hospital, Clinic of Rheumatology, Ankara, Turkey.

Ankara City Hospital, Clinic of Rheumatology, Ankara, Turkey.

出版信息

Int J Clin Pract. 2022 Mar 24;2022:7243399. doi: 10.1155/2022/7243399. eCollection 2022.

DOI:10.1155/2022/7243399
PMID:35685583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9159165/
Abstract

BACKGROUND

In clinical practice, it is hard to judge the level of disease activity in some patients with ankylosing spondylitis (AS) who have low traditional acute phase reactant values such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) but have considerable pain and inflammation. The aim of this study is to investigate plasma pentraxin 3 (PTX3) and serum amyloid P (SAP) levels in patients with AS who had normal ESR and CRP but high disease activity.

METHODS

100 AS patients and 100 gender- and age-matched controls were included. Epidemiological, clinical, and treatment data and plasma levels of CRP, ESR, PTX3, and SAP were evaluated. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Ankylosing Spondylitis Disease Activity Score (ASDAS)-CRP were used for evaluating disease activity. Plasma levels of PTX3 and SAP were compared between AS patients and controls and also among AS patients with active and inactive disease.

RESULTS

AS patients had significantly higher plasma levels of PTX3 and SAP than controls. There were not any significant correlations between PTX3 and SAP with BASDAI, ASDAS-CRP, and ESR. There was a positive correlation between PTX3 and CRP. No significant difference in plasma levels of PTX3 and SAP was observed between patients with active disease and inactive disease, both with normal ESR and CRP levels. Disease duration and treatment did not influence plasma PTX3 levels.

CONCLUSIONS

In patients with AS, plasma levels of PTX3 and SAP were found to be elevated when compared to healthy controls. No association was observed between these biomarkers and disease activity.

摘要

背景

在临床实践中,对于红细胞沉降率(ESR)和 C 反应蛋白(CRP)等传统急性期反应物值较低但疼痛和炎症明显的某些强直性脊柱炎(AS)患者,很难判断疾病活动度。本研究旨在探讨 ESR 和 CRP 正常但疾病活动度高的 AS 患者血浆五聚素 3(PTX3)和血清淀粉样蛋白 P(SAP)水平。

方法

纳入 100 例 AS 患者和 100 名性别和年龄匹配的对照者。评估了流行病学、临床和治疗数据以及 CRP、ESR、PTX3 和 SAP 的血浆水平。采用 Bath 强直性脊柱炎疾病活动指数(BASDAI)和强直性脊柱炎疾病活动评分(ASDAS-CRP)评估疾病活动度。比较了 AS 患者与对照组及疾病活动期与非活动期 AS 患者的血浆 PTX3 和 SAP 水平。

结果

AS 患者的血浆 PTX3 和 SAP 水平明显高于对照组。PTX3 和 SAP 与 BASDAI、ASDAS-CRP 和 ESR 之间均无显著相关性。PTX3 与 CRP 呈正相关。ESR 和 CRP 正常的活动期和非活动期 AS 患者的血浆 PTX3 和 SAP 水平无显著差异。疾病持续时间和治疗不影响血浆 PTX3 水平。

结论

与健康对照者相比,AS 患者的血浆 PTX3 和 SAP 水平升高,但这些生物标志物与疾病活动度之间无关联。

相似文献

1
The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis.血浆 pentraxin 3 与血清淀粉样蛋白 P 水平与强直性脊柱炎疾病活动度的关系。
Int J Clin Pract. 2022 Mar 24;2022:7243399. doi: 10.1155/2022/7243399. eCollection 2022.
2
Plasma levels of pentraxin 3 in patients with spondyloarthritis.脊柱关节炎患者血浆中五聚体蛋白3的水平
Biomarkers. 2018 Feb;23(1):14-17. doi: 10.1080/1354750X.2016.1278265. Epub 2017 Jan 17.
3
Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis.
Acta Reumatol Port. 2014 Apr-Jun;39(2):137-42.
4
The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.Bath 强直性脊柱炎疾病活动指数、强直性脊柱炎疾病活动评分、C 反应蛋白和红细胞沉降率在脊柱关节炎相关轴性关节炎中的鉴别价值。
J Clin Rheumatol. 2017 Aug;23(5):267-272. doi: 10.1097/RHU.0000000000000522.
5
Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.血小板与白蛋白比值是强直性脊柱炎疾病活动的独立指标。
Clin Rheumatol. 2023 Feb;42(2):407-413. doi: 10.1007/s10067-022-06439-x. Epub 2022 Nov 21.
6
Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.强直性脊柱炎疾病活动评分(ASDAS)在非放射学轴性脊柱关节炎和强直性脊柱炎患者中的判别效度:一项队列研究
Rheumatol Int. 2015 Jun;35(6):981-9. doi: 10.1007/s00296-014-3168-y. Epub 2014 Nov 4.
7
Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?在轴性脊柱关节炎患者中,强直性脊柱炎疾病活动评分的临界值是否存在性别差异?
Int J Rheum Dis. 2017 Sep;20(9):1201-1211. doi: 10.1111/1756-185X.12885. Epub 2016 Jun 16.
8
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.强直性脊柱炎疾病活动度评分简化版(SASDAS)用于评估中轴型脊柱关节炎疾病活动度的结构效度和反应性。
Health Qual Life Outcomes. 2014 Aug 22;12:129. doi: 10.1186/s12955-014-0129-9.
9
Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients.简化强直性脊柱炎疾病活动度评分(SASDAS)在印度强直性脊柱炎患者中的有效性
J Clin Diagn Res. 2017 Sep;11(9):OC06-OC09. doi: 10.7860/JCDR/2017/22665.10540. Epub 2017 Sep 1.
10
Gender difference in ASAS HI among patients with ankylosing spondylitis.性别差异在强直性脊柱炎患者 ASAS HI 中。
PLoS One. 2020 Jul 9;15(7):e0235678. doi: 10.1371/journal.pone.0235678. eCollection 2020.

引用本文的文献

1
The Role of Pentraxin 3 in the Assessment of Cardiovascular Risk and Disease Activity in Patients with Rheumatoid Arthritis and Spondyloarthritis.五聚体蛋白3在类风湿关节炎和脊柱关节炎患者心血管风险评估及疾病活动度评估中的作用
J Inflamm Res. 2024 Nov 27;17:9905-9916. doi: 10.2147/JIR.S497265. eCollection 2024.
2
Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis.生物标志物在中轴型脊柱关节炎中的实际意义:诊断、疾病活动度和预后的更新。
Int J Mol Sci. 2022 Sep 30;23(19):11561. doi: 10.3390/ijms231911561.

本文引用的文献

1
Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response.循环和滑液 Pentraxin-3(PTX3)表达水平与类风湿关节炎严重程度和组织浸润相关,与常规治疗反应无关。
Front Immunol. 2021 Jun 25;12:686795. doi: 10.3389/fimmu.2021.686795. eCollection 2021.
2
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.抗风湿治疗与类风湿关节炎、银屑病关节炎和强直性脊柱炎中五聚体蛋白3的降低无关。
PLoS One. 2017 Feb 22;12(2):e0169830. doi: 10.1371/journal.pone.0169830. eCollection 2017.
3
Plasma levels of pentraxin 3 in patients with spondyloarthritis.脊柱关节炎患者血浆中五聚体蛋白3的水平
Biomarkers. 2018 Feb;23(1):14-17. doi: 10.1080/1354750X.2016.1278265. Epub 2017 Jan 17.
4
Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis.五聚体蛋白3基因中的遗传变异与强直性脊柱炎的关联
Med Sci Monit. 2016 Aug 18;22:2911-6. doi: 10.12659/msm.896562.
5
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling.五聚素PTX3和血清淀粉样蛋白P在固有免疫、炎症调节及组织重塑中的作用
J Hepatol. 2016 Jun;64(6):1416-27. doi: 10.1016/j.jhep.2016.02.029. Epub 2016 Feb 26.
6
Reduction of Inflammation Drives Lipid Changes in Ankylosing Spondylitis.炎症减轻促使强直性脊柱炎患者脂质变化。
J Rheumatol. 2015 Oct;42(10):1842-5. doi: 10.3899/jrheum.150193. Epub 2015 Sep 1.
7
Risk Factors of Heterotopic Ossification Following Total Hip Arthroplasty in Patients With Ankylosing Spondylitis.强直性脊柱炎患者全髋关节置换术后异位骨化的危险因素
J Arthroplasty. 2015 Dec;30(12):2304-7. doi: 10.1016/j.arth.2015.06.013. Epub 2015 Jun 14.
8
Association between rs7517847 and rs2201841 polymorphisms in IL-23 receptor gene and risk of ankylosing spondylitis: a meta-analysis.白细胞介素-23受体基因中rs7517847和rs2201841多态性与强直性脊柱炎风险的关联:一项荟萃分析。
PeerJ. 2015 Apr 23;3:e910. doi: 10.7717/peerj.910. eCollection 2015.
9
Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis.
Acta Reumatol Port. 2014 Apr-Jun;39(2):137-42.
10
Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.Pentraxin 3 与系统性红斑狼疮患者的疾病活动度相关,但与动脉粥样硬化无关。
Mod Rheumatol. 2014 Jan;24(1):78-85. doi: 10.3109/14397595.2013.852837.